Healthcare · Medical Devices
Neuralink
Fremont, California, USA · Series E
Implied valuation
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Factor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Mixed signals — limited valuation history with 16% modeled IPO odds keep down-round risk in the middle band.
Asset brief
Neuralink is a Healthcare · Medical Devices company last marked at $9.65B. Stage: Series E, $650MM raised to date. No verified market-moving events in the last 30 days.
Neuralink is a neurotechnology company developing implantable brain-computer interfaces (BCIs). The company's mission is to create a generalized brain interface to restore autonomy to individuals with unmet medical needs and to unlock human potential.
Capital Timeline
Funding & liquidity milestones
Series E
$650MM raised · $9.65B